| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |